| Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers AA Gaber, AH Bayoumi, AM El-Morsy, FF Sherbiny, ABM Mehany, ... Bioorganic chemistry 80, 375-395, 2018 | 126 | 2018 |
| Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual … M Alswah, AH Bayoumi, K Elgamal, A Elmorsy, S Ihmaid, HEA Ahmed Molecules 23 (1), 48, 2017 | 96 | 2017 |
| From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity MH El-Shershaby, A Ghiaty, AH Bayoumi, AA Al-Karmalawy, ... Bioorganic & Medicinal Chemistry 42, 116266, 2021 | 59 | 2021 |
| Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors EA Fayed, YA Ammar, MA Saleh, AH Bayoumi, A Belal, ABM Mehany, ... Journal of Molecular Structure 1236, 130317, 2021 | 56 | 2021 |
| The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors MH El-Shershaby, KM El-Gamal, AH Bayoumi, K El-Adl, M Alswah, ... New Journal of Chemistry 45 (31), 13986-14004, 2021 | 55 | 2021 |
| Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies A Turky, AH Bayoumi, FF Sherbiny, K El-Adl, HS Abulkhair Molecular diversity 25, 403-420, 2021 | 51 | 2021 |
| In vivo screening and toxicity studies of indolinone incorporated thiosemicarbazone, thiazole and piperidinosulfonyl moieties as anticonvulsant agents EA Fayed, A Ragab, RRE Eldin, AH Bayoumi, YA Ammar Bioorganic Chemistry 116, 105300, 2021 | 50 | 2021 |
| Pharmacophore‐linked pyrazolo[3,4‐d]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies AA Gaber, AM El‐Morsy, FF Sherbiny, AH Bayoumi, KM El‐Gamal, ... Archiv Der Pharmazie, e2100258, 2021 | 48 | 2021 |
| Isatin-Schiff's base and chalcone hybrids as chemically apoptotic inducers and EGFR inhibitors; design, synthesis, anti-proliferative activities and in silico evaluation EA Fayed, RRE Eldin, ABM Mehany, AH Bayoumi, YA Ammar Journal of Molecular Structure 1234, 130159, 2021 | 48 | 2021 |
| Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies HS Abulkhair, A Turky, A Ghiaty, HEA Ahmed, AH Bayoumi Bioorganic Chemistry 100, 103899, 2020 | 48 | 2020 |
| Synthesis and anticancer evaluation of some novel 5‐amino [1, 2, 4] triazole derivatives AY Hassan, MT Sarg, AH Bayoumi, MA El‐Deeb Journal of Heterocyclic Chemistry 55 (6), 1450-1478, 2018 | 47 | 2018 |
| Design, synthesis, and antitumor activity of novel compounds based on 1, 2, 4-triazolophthalazine scaffold: apoptosis-inductive and PCAF-inhibitory effects A Turky, AH Bayoumi, A Ghiaty, AS El-Azab, AM Alaa, HS Abulkhair Bioorganic Chemistry 101, 104019, 2020 | 45 | 2020 |
| Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity A Kotb, NS Abutaleb, MA Seleem, M Hagras, H Mohammad, A Bayoumi, ... European journal of medicinal chemistry 151, 110-120, 2018 | 45 | 2018 |
| Synthesis and Evaluation of Some New (1, 2, 4) Triazolo (4, 3‐a) Quinoxalin‐4 (5H)‐one Derivatives as AMPA Receptor Antagonists H Abul‐Khair, S Elmeligie, A Bayoumi, A Ghiaty, A El‐Morsy, MH Hassan Journal of Heterocyclic Chemistry 50 (5), 1202-1208, 2013 | 42 | 2013 |
| 1, 2, 4-Triazolo [4, 3-c] quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity MH El-Shershaby, A Ghiaty, AH Bayoumi, HEA Ahmed, MS El-Zoghbi, ... New Journal of Chemistry 45 (25), 11136-11152, 2021 | 41 | 2021 |
| Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives MH El‐Shershaby, KM El‐Gamal, AH Bayoumi, K El‐Adl, HEA Ahmed, ... Archiv der Pharmazie 354 (2), 2000277, 2021 | 40 | 2021 |
| In vivo‐and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors HS Abulkhair, S Elmeligie, A Ghiaty, A El‐Morsy, AH Bayoumi, ... Archiv der Pharmazie 354 (5), 2000449, 2021 | 38 | 2021 |
| Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists HG Ezzat, AH Bayoumi, FF Sherbiny, AM El-Morsy, A Ghiaty, M Alswah, ... Molecular Diversity 25, 291-306, 2021 | 37 | 2021 |
| Novel 1, 2, 4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies A Turky, FF Sherbiny, AH Bayoumi, HEA Ahmed, HS Abulkhair Archiv der Pharmazie 353 (12), 2000170, 2020 | 37 | 2020 |
| Design, synthesis, cytotoxicity and molecular modeling studies of some novel fluorinated pyrazole-based heterocycles as anticancer and apoptosis-inducing agents EA Fayed, SI Eissa, AH Bayoumi, NA Gohar, ABM Mehany, YA Ammar Molecular diversity 23, 165-181, 2019 | 36 | 2019 |
Hamada S. AbulkhairProfessor of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Al-Azhar UniversityE-mailová adresa ověřena na: horus.edu.eg